Covetrus Inc (NASDAQ:CVET) insider Erin Powers Brennan acquired 1,684 shares of the business’s stock in a transaction on Wednesday, August 21st. The stock was purchased at an average price of $14.90 per share, for a total transaction of $25,091.60. The purchase was disclosed in a filing with the SEC, which is available through the SEC website.

Shares of Covetrus stock traded down $1.04 during trading on Wednesday, reaching $13.80. The company had a trading volume of 2,494,089 shares, compared to its average volume of 1,653,508. The firm’s fifty day simple moving average is $22.41. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.91 and a current ratio of 1.74. Covetrus Inc has a fifty-two week low of $12.22 and a fifty-two week high of $43.83.

Covetrus (NASDAQ:CVET) last issued its earnings results on Tuesday, August 13th. The company reported $0.12 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.16 by ($0.04). The firm had revenue of $1.01 billion for the quarter, compared to analyst estimates of $1.05 billion. On average, equities analysts predict that Covetrus Inc will post 0.4 earnings per share for the current year.

A number of equities analysts have commented on CVET shares. Zacks Investment Research lowered shares of Covetrus from a “buy” rating to a “hold” rating in a report on Wednesday, July 17th. Credit Suisse Group set a $15.00 price objective on shares of Covetrus and gave the stock a “hold” rating in a report on Friday, August 16th. Raymond James cut their price objective on shares of Covetrus from $45.00 to $21.00 and set an “outperform” rating on the stock in a report on Thursday, August 15th. Stifel Nicolaus cut their price objective on shares of Covetrus from $30.00 to $18.00 and set a “hold” rating on the stock in a report on Wednesday, August 14th. Finally, ValuEngine lowered shares of Covetrus from a “buy” rating to a “hold” rating in a report on Tuesday, August 13th. Six equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus price target of $20.75.

An institutional investor recently bought a new position in Covetrus stock. Gamble Jones Investment Counsel bought a new stake in Covetrus Inc (NASDAQ:CVET) during the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 77,986 shares of the company’s stock, valued at approximately $1,908,000. Gamble Jones Investment Counsel owned approximately 0.07% of Covetrus as of its most recent filing with the SEC. Institutional investors own 75.10% of the company’s stock.

Covetrus Company Profile

Covetrus, Inc engages in developing technologies and services for animal health industry. It also provides products, software, and services to help drive improved patient health, strong client relationships, and successful financial outcomes for veterinary professionals. The company was founded on April 13, 2018 and is headquartered in Melville, NY.

Further Reading: What is the CBOE Russell 2000® Volatility Index?

Receive News & Ratings for Covetrus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Covetrus and related companies with MarketBeat.com's FREE daily email newsletter.